CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 74 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | -38.2% | 83,409 | +29.8% | 0.00% | – |
| Q1 2022 | $34,000 | -50.0% | 64,247 | -41.9% | 0.00% | – |
| Q4 2021 | $68,000 | +6.2% | 110,646 | +73.5% | 0.00% | – |
| Q3 2021 | $64,000 | -76.9% | 63,790 | -57.9% | 0.00% | – |
| Q2 2021 | $277,000 | -47.0% | 151,367 | -43.0% | 0.00% | – |
| Q1 2021 | $523,000 | +44.9% | 265,408 | -7.9% | 0.00% | – |
| Q4 2020 | $361,000 | -84.5% | 288,228 | -77.7% | 0.00% | -100.0% |
| Q3 2020 | $2,326,000 | +18.3% | 1,292,165 | +451.4% | 0.00% | 0.0% |
| Q2 2020 | $1,966,000 | +2388.6% | 234,322 | +1449.4% | 0.00% | – |
| Q1 2020 | $79,000 | -86.2% | 15,123 | -77.6% | 0.00% | -100.0% |
| Q4 2016 | $572,000 | +439.6% | 67,648 | +333.1% | 0.00% | +100.0% |
| Q3 2016 | $106,000 | – | 15,618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $42,335,000 | 24.44% |
| MANGROVE PARTNERS IM, LLC | 552,200 | $4,633,000 | 1.13% |
| ETF MANAGERS GROUP, LLC | 3,707,912 | $31,109,000 | 1.10% |
| Ikarian Capital, LLC | 1,350,000 | $11,327,000 | 0.90% |
| GENERAL AMERICAN INVESTORS CO INC | 712,400 | $5,977,000 | 0.76% |
| AdvisorShares Investments LLC | 189,814 | $1,593,000 | 0.68% |
| Ikarian Capital, LLC | 1,000,000 | $8,390,000 | 0.67% |
| Granite Point Capital Management, L.P. | 1,123,600 | $9,427,000 | 0.48% |
| Carmignac Gestion | 3,773,440 | $31,659,000 | 0.44% |
| Omnia Family Wealth, LLC | 32,356 | $271,467,000 | 0.27% |